bucladesine has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, ES; Barritt, GJ; Hua, J; Rychkov, GY; Tallis, GA; Wilson, CH; Zhou, FH | 1 |
| Bradford, BU; Brenner, DA; Enomoto, A; Enomoto, N; Ikejima, K; Nishimura, T; Nishiura, T; Rivera, CA; Schemmer, P; Thurman, RG; Yamashina, S; Zhong, Z | 1 |
2 other study(ies) available for bucladesine and Liver Steatosis
| Article | Year |
|---|---|
The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca(2+) signalling in steatotic hepatocytes.
Topics: Animals; Bucladesine; Calcium; Calcium Signaling; Cyclic AMP; Exenatide; Fatty Liver; Glucagon-Like Peptide 1; Hepatocytes; Hormones; Intracellular Space; Palmitic Acid; Peptides; Rats, Zucker; Venoms | 2016 |
Kupffer cell-derived prostaglandin E(2) is involved in alcohol-induced fat accumulation in rat liver.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Anti-Bacterial Agents; Bucladesine; Calcium Channel Blockers; Cells, Cultured; Central Nervous System Depressants; Culture Media, Conditioned; Cyclic AMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Ethanol; Fatty Liver; Female; Gene Expression Regulation, Enzymologic; Indomethacin; Isoenzymes; Kupffer Cells; Lipopolysaccharides; Liver Cirrhosis, Alcoholic; Nimodipine; Oligonucleotide Probes; Organ Size; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triglycerides | 2000 |